Carolina R Melo-Silva

Dr. Carolina R Melo-Silva

Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Mississippi, USA
orcid
Instructor at the Department of Immunology and Microbiology,...

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
NVNguyen T. Van
Nguyen T. Van
KZKaren Zhang
Karen Zhang
RWRachel M. Wigmore
Rachel M. Wigmore
AKAnne I. Kennedy
Anne I. Kennedy
Carolina R Melo-SilvaCarolina R Melo-Silva
Carolina R Melo-Silva
SKSangwon Vincent Kim
Sangwon Vincent Kim
Environmental factors are the major contributor to the onset of immunological disorders such as ulcerative colitis. However, their identities remain unclear. Here, we discover that the amount of consumed L-Tryptophan (L-Trp), a ubiquitous dietary component, determines the transcription level of the colonic T cell homing receptor, GPR15, hence affecting the number of colonic FOXP3+ regulatory T (Treg) cells and local immune homeostasis. Ingested L-Trp is converted by host IDO1/2 enzymes, but not by gut microbiota, to compounds that induce GPR15 transcription preferentially in Treg cells via the aryl hydrocarbon receptor. Consequently, two weeks of dietary L-Trp supplementation nearly double the colonic GPR15+ Treg cells via GPR15-mediated homing and substantially reduce the future risk of colitis. In addition, humans consume 3–4 times less L-Trp per kilogram of body weight and have fewer colonic GPR15+ Treg cells than mice. Thus, we uncover a microbiota-independent mechanism linking dietary L-Trp and colonic Treg cells, that may have therapeutic potential.

9 September 2021 in Journal of Virology
Verified
Journal Article
Closed access
CKCory J. Knudson
Cory J. Knudson
MFMaria Férez
Maria Férez
PAPedro Alves-Peixoto
Pedro Alves-Peixoto
DEDan A. Erkes
Dan A. Erkes
Carolina R Melo-SilvaCarolina R Melo-Silva
Carolina R Melo-Silva
LSLuis Sigal
Luis Sigal
While it is well established that cytotoxic CD4 T cells (CD4-CTLs) directly contribute to viral clearance, it remains unclear how CD4-CTL are induced. We now show that CD4-CTLs require sustained antigen presentation and are induced by CD11c-expressing antigen-presenting cells.

15 August 2017 in Immunology & Cell Biology
Verified
Journal Article
Closed access
MMMatthew S Mangan
Matthew S Mangan
Carolina R Melo-SilvaCarolina R Melo-Silva
Carolina R Melo-Silva
JLJennii Luu
Jennii Luu
CBCatherina H Bird
Catherina H Bird
AKAulikki Koskinen
Aulikki Koskinen
PBPhillip I Bird
Phillip I Bird

1 January 2011 in Journal of Virological Methods
Verified
Journal Article
Closed access
YWYik Chun Wong
Yik Chun Wong
LLLeon C.W. Lin
Leon C.W. Lin
Carolina R Melo-SilvaCarolina R Melo-Silva
Carolina R Melo-Silva
SSStewart A. Smith
Stewart A. Smith
DTDavid Tscharke
David Tscharke

25 June 2024 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
Carolina R Melo-SilvaCarolina R Melo-Silva
Carolina R Melo-Silva
LSLuis Sigal
Luis Sigal
The interstitial fluids in tissues are constantly drained into the lymph nodes (LNs) as lymph through afferent lymphatic vessels and from LNs into the blood through efferent lymphatics. LNs are strategically positioned and have the appropriate cellular composition to serve as sites of adaptive immune initiation against invading pathogens. However, for lymph-borne viruses, which disseminate from the entry site to other tissues through the lymphatic system, immune cells in the draining LN (dLN) also play critical roles in curbing systemic viral dissemination during primary and secondary infections. Lymph-borne viruses in tissues can be transported to dLNs as free virions in the lymph or within infected cells. Regardless of the entry mechanism, infected myeloid antigen-presenting cells, including various subtypes of dendritic cells, inflammatory monocytes, and macrophages, play a critical role in initiating the innate immune response within the dLN. This innate immune response involves cellular crosstalk between infected and bystander innate immune cells that ultimately produce type I interferons (IFN-Is) and other cytokines and recruit inflammatory monocytes and natural killer (NK) cells. IFN-I and NK cell cytotoxicity can restrict systemic viral spread during primary infections and prevent serious disease. Additionally, the memory CD8+ T-cells that reside or rapidly migrate to the dLN can contribute to disease prevention during secondary viral infections. This review explores the intricate innate immune responses orchestrated within dLNs that contain primary viral infections and the role of memory CD8+ T-cells following secondary infection or CD8+ T-cell vaccination.

1 November 2011 in Journal of Virology
Verified
Journal Article
Closed access
Carolina R Melo-SilvaCarolina R Melo-Silva
Carolina R Melo-Silva
DTDavid Tscharke
David Tscharke
MLMario Lobigs
Mario Lobigs
AKAulikki Koskinen
Aulikki Koskinen
YWYik Chun Wong
Yik Chun Wong
MRMatthias Regner
Matthias Regner
Ectromelia virus (ECTV) is a natural pathogen of mice that causes mousepox, and many of its genes have been implicated in the modulation of host immune responses. Serine protease inhibitor 2 (SPI-2) is one of these putative ECTV host response modifier proteins. SPI-2 is conserved across orthopoxviruses, but results defining its mechanism of action andin vivofunction are lacking or contradictory. We studied the role of SPI-2 in mousepox by deleting theSPI-2gene or its serine protease inhibitor reactive site. We found that SPI-2 does not affect viral replication or cell-intrinsic apoptosis pathways, since mutant viruses replicatein vitroas efficiently as wild-type virus. However, in the absence of SPI-2 protein, ECTV is attenuated in mousepox-susceptible mice, resulting in lower viral loads in the liver, decreased spleen pathology, and substantially improved host survival. This attenuation correlates with more effective immune responses in the absence of SPI-2, including an earlier serum gamma interferon (IFN-γ) response, raised serum interleukin 18 (IL-18), increased numbers of granzyme B+CD8+T cells, and, most notably, increased numbers and activation of NK cells. Both virus attenuation and the improved immune responses associated with SPI-2 deletion from ECTV are lost when mice are depleted of NK cells. Consequently, SPI-2 renders mousepox lethal in susceptible strains by preventing protective NK cell defenses.